Neogen (NEOG) Scheduled to Post Quarterly Earnings on Tuesday

Neogen (NASDAQ:NEOG) will issue its quarterly earnings data before the market opens on Tuesday, April 9th. Analysts expect the company to announce earnings of $0.14 per share for the quarter. Neogen has set its FY 2024 guidance at EPS.Parties interested in participating in the company’s conference call can do so using this link.

Neogen (NASDAQ:NEOG) last issued its earnings results on Tuesday, January 9th. The company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.08. Neogen had a return on equity of 3.35% and a net margin of 1.28%. The business had revenue of $229.60 million during the quarter, compared to analysts’ expectations of $232.85 million. During the same period in the prior year, the firm posted $0.15 EPS. Neogen’s quarterly revenue was down .2% compared to the same quarter last year. On average, analysts expect Neogen to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Neogen Trading Up 1.9 %

Shares of NEOG opened at $14.35 on Monday. Neogen has a 1 year low of $13.94 and a 1 year high of $24.09. The company has a current ratio of 3.54, a quick ratio of 2.63 and a debt-to-equity ratio of 0.28. The stock has a 50 day simple moving average of $16.08 and a 200-day simple moving average of $16.91. The stock has a market cap of $3.11 billion, a PE ratio of 239.21 and a beta of 1.13.

Analyst Ratings Changes

Separately, Piper Sandler increased their target price on Neogen from $17.50 to $19.00 and gave the stock a “neutral” rating in a report on Thursday, January 18th.

Institutional Investors Weigh In On Neogen

A number of large investors have recently bought and sold shares of NEOG. Fairfield Bush & CO. grew its position in Neogen by 3.5% during the 1st quarter. Fairfield Bush & CO. now owns 75,222 shares of the company’s stock worth $2,320,000 after acquiring an additional 2,572 shares during the last quarter. Raymond James & Associates grew its position in Neogen by 3.3% during the 1st quarter. Raymond James & Associates now owns 124,917 shares of the company’s stock worth $3,852,000 after acquiring an additional 3,974 shares during the last quarter. HighTower Advisors LLC grew its position in Neogen by 3.6% during the 1st quarter. HighTower Advisors LLC now owns 44,465 shares of the company’s stock worth $1,373,000 after acquiring an additional 1,540 shares during the last quarter. Panagora Asset Management Inc. grew its position in Neogen by 29.3% during the 1st quarter. Panagora Asset Management Inc. now owns 20,573 shares of the company’s stock worth $634,000 after acquiring an additional 4,661 shares during the last quarter. Finally, Rhumbline Advisers grew its position in Neogen by 2.3% during the 1st quarter. Rhumbline Advisers now owns 305,783 shares of the company’s stock worth $9,430,000 after acquiring an additional 6,931 shares during the last quarter. 96.73% of the stock is currently owned by institutional investors.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.